PhoenixBio Co FCF per Share
The Free Cash Flow per Share of PhoenixBio Co (6190.T) as of Sep 26, 2026 is -26.04 JPY. In the previous year, Free Cash Flow per Share was -31.22 JPY — a change of -16.60% (higher).
Get this data via API
Financial Data API
FCF per Share
-26.04JPY
YoY
-16.60%
Last updated:
The PhoenixBio Co FCF per Share history
3 Years
10 Years
25 Years
Max
| YEAR | FCF per Share | YoY |
|---|---|---|
| -26.04JPY | -16.60% | |
| -31.22JPY | -159.72% | |
| 52.29JPY | +1,693.30% | |
| 2.92JPY | -103.32% | |
| -87.89JPY | +495.68% | |
| -14.76JPY | -80.87% | |
| -77.13JPY | +15.58% | |
| -66.73JPY | -650.07% | |
| 12.13JPY | -86.91% | |
| 92.67JPY | -1,579.72% | |
| -6.26JPY | -113.31% | |
| 47.04JPY | — |
PhoenixBio Co Stock analysis
Frequently Asked Questions about PhoenixBio Co stock
Free Cash Flow per Share of PhoenixBio Co is -26.04 JPY in 2026.
Free Cash Flow per Share of PhoenixBio Co changed from -31.22 JPY to -26.04 JPY, representing a -16.60% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Free Cash Flow per Share PhoenixBio Co since 2006 – with annual values, charts, and detailed analysis.
FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.
Cash Flow — PhoenixBio Co
All Key Metrics — PhoenixBio Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth